ATE269104T1 - Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert - Google Patents

Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert

Info

Publication number
ATE269104T1
ATE269104T1 AT00204630T AT00204630T ATE269104T1 AT E269104 T1 ATE269104 T1 AT E269104T1 AT 00204630 T AT00204630 T AT 00204630T AT 00204630 T AT00204630 T AT 00204630T AT E269104 T1 ATE269104 T1 AT E269104T1
Authority
AT
Austria
Prior art keywords
flagella
flagellin
induce antibodies
salmonella vaccine
relates
Prior art date
Application number
AT00204630T
Other languages
English (en)
Inventor
Petrus Johannes Maria Nuijten
Maarten Hendrik Witvliet
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE269104T1 publication Critical patent/ATE269104T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00204630T 1999-12-28 2000-12-19 Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert ATE269104T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204564 1999-12-28

Publications (1)

Publication Number Publication Date
ATE269104T1 true ATE269104T1 (de) 2004-07-15

Family

ID=8241112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00204630T ATE269104T1 (de) 1999-12-28 2000-12-19 Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert

Country Status (15)

Country Link
US (2) US20010021386A1 (de)
EP (1) EP1112747B1 (de)
JP (1) JP5745731B2 (de)
AT (1) ATE269104T1 (de)
AU (1) AU783508B2 (de)
BR (1) BR0006291B1 (de)
CA (1) CA2329676A1 (de)
DE (1) DE60011560T2 (de)
DK (1) DK1112747T3 (de)
ES (1) ES2222152T3 (de)
HU (1) HU226192B1 (de)
MX (1) MXPA00012796A (de)
PL (1) PL206377B1 (de)
PT (1) PT1112747E (de)
TR (1) TR200401569T4 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4751570B2 (ja) * 2002-09-11 2011-08-17 東レ・ダウコーニング株式会社 オルガノポリシロキサン変性多糖類およびその製造方法
EP2857038B1 (de) 2006-09-18 2019-04-10 The Board of Trustees of the University of Arkansas Zusammensetzungen und Verfahren zur Verstärkung von Immunreaktionen
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
US9125854B2 (en) * 2007-10-30 2015-09-08 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
PT2214701T (pt) 2007-11-01 2016-11-02 Univ Guelph Composições e métodos de potenciar respostas imunes a eimeria
EP2217716A4 (de) 2007-11-09 2011-02-09 Salk Inst For Biological Studi Verwendung von tam-rezeptor-inhibitoren als antimikrobielle mittel
NO2525817T3 (de) 2010-01-21 2018-01-06
BR112012031211A2 (pt) 2010-06-09 2018-01-30 Univ Arkansas métodos e vacina para reduzir a infecção causada pelo campylobacter
KR101449417B1 (ko) 2012-06-20 2014-10-27 한국외국어대학교 연구산학협력단 살모넬라 엔테리카의 박테리오파아지 및 그 용도
RU2683027C2 (ru) 2012-12-20 2019-03-26 Заклад Бадавчо-Вдроженёвы Осьродка Сальмонельля "Иммуноляб" Сп. З О.О. Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
EP2956165B1 (de) 2013-02-14 2019-09-11 The Board of Trustees of the University of Arkansas Zusammensetzungen und verfahren zur verstärkung von immunreaktionen gegenüber eimeria oder zur begrenzung von eimeria-infektionen
US9845341B2 (en) 2013-03-11 2017-12-19 The Brigham And Women's Hospital, Inc. Vibro-based delivery system and immune suppression
CN105142653B (zh) 2013-03-15 2019-11-15 阿肯色大学评议会 增强对肠病原体免疫应答的组合物和方法
AR108688A1 (es) 2016-05-03 2018-09-19 Univ Arkansas Vector de vacuna de levadura que incluye polipéptidos inmunoestimuladores y antigénicos, métodos para su uso
CN111374094B (zh) * 2020-03-02 2022-04-19 扬州大学 驴源马流产沙门氏菌经皮下致非妊娠期小鼠子宫感染模型的建立方法
CN118773056B (zh) * 2024-07-10 2025-07-08 山东省滨州畜牧兽医研究院 一种马流产沙门氏菌灭活疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1109179A (en) * 1964-09-30 1968-04-10 Nat Res Dev Improvements relating to typhoid and paratyphoid vaccines
DE3787820T2 (de) * 1986-03-11 1994-04-28 Shionogi & Co Für Flagellin kodierende DNS und dieses enthaltender Vektor.
JP2793673B2 (ja) * 1988-05-05 1998-09-03 アメリカン・サイアナミド・カンパニー 組み換えフラジエリンのワクチン
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
EP0449958B9 (de) * 1988-12-19 2003-05-28 American Cyanamid Company Meningococcales klasse i-aussenmembranprotein-vakzin
NZ281797A (en) * 1994-02-18 1997-04-24 Innovac Co Inoculation of animals by inserting dried pelleted biological materials into the animal's ear
GB9621091D0 (en) * 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
HU0005010D0 (de) 2001-02-28
MXPA00012796A (es) 2002-05-23
DE60011560T2 (de) 2005-08-18
HU226192B1 (en) 2008-06-30
BR0006291B1 (pt) 2014-02-18
CA2329676A1 (en) 2001-06-28
DK1112747T3 (da) 2004-10-25
PL344851A1 (en) 2001-07-02
PT1112747E (pt) 2004-10-29
AU783508B2 (en) 2005-11-03
HUP0005010A2 (en) 2002-06-29
JP2001186874A (ja) 2001-07-10
ES2222152T3 (es) 2005-02-01
US20080069843A1 (en) 2008-03-20
US20010021386A1 (en) 2001-09-13
BR0006291A (pt) 2001-11-27
EP1112747B1 (de) 2004-06-16
EP1112747A1 (de) 2001-07-04
JP5745731B2 (ja) 2015-07-08
DE60011560D1 (de) 2004-07-22
HUP0005010A3 (en) 2004-07-28
TR200401569T4 (tr) 2004-07-21
AU7245300A (en) 2001-07-05
PL206377B1 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
DE60011560D1 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
EP1499191A4 (de) Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
MX393384B (es) Adyuvantes sinteticos de glucopiranosil-lipido.
WO2004060308A3 (en) Thiosemicarbazones as anti-virals and immunopotentiators
CY1106467T1 (el) Ελεγχομενη συνθεση ζιπρασιδονης
ATE263157T1 (de) Nematizide trifluorbutene
CY1110537T1 (el) Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας
CY1108808T1 (el) Ενωσεις μοτιλιδης
ATE413888T1 (de) Salmonella vakzine
ATE308992T1 (de) Attenuierte bakterien verwendbar als impstoffe
ATE518012T1 (de) Isolate des das reproduktions- und atemwegssyndrom verursachenden schweinevirus und ihre verwendung
ZA200000370B (en) Novel antigenic class of avian reoviruses.
CY1109496T1 (el) Τρυγικο και φωσφορικο αλας της 3,4-διαμινοπυριδινης, φαρμακευτικες συνθεσεις και χρησεις αυτων
ATE380557T1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
SG147465A1 (en) Vaccine
DE60042489D1 (de) Impfstoff gegen neisseria infektion
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
GB0317733D0 (en) Organic compounds
WO2005021031A3 (en) Live attenuated bacterial vaccine
GB0409559D0 (en) Polypeptide
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
CY1114309T1 (el) Εμβολιο ροταϊου

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1112747

Country of ref document: EP